Literature DB >> 31990697

Esophageal Hypervigilance and Visceral Anxiety Are Contributors to Symptom Severity Among Patients Evaluated With High-Resolution Esophageal Manometry.

Dustin A Carlson1, C Prakash Gyawali2, Sabine Roman3, Marcelo Vela4, Tiffany H Taft1, Michael D Crowell4, Karthik Ravi5, Joseph R Triggs1, Farhan Quader2, Jacqueline Prescott1, Frederick T J Lin1, Francois Mion3, Dario Biasutto3, Laurie Keefer6, Peter J Kahrilas1, John E Pandolfino1.   

Abstract

OBJECTIVES: Symptoms are inconsistently associated with esophageal motor findings on high-resolution manometry (HRM). We aimed to evaluate predictors of dysphagia severity, including esophageal hypervigilance and visceral anxiety, among patients evaluated with HRM.
METHODS: Adult patients undergoing HRM at 4 academic medical centers (United States and France) were prospectively evaluated. HRM was completed and analyzed per the Chicago Classification v3.0. Validated symptom scores, including the Brief Esophageal Dysphagia Questionnaire and Esophageal Hypervigilance and Anxiety Scale, were completed at the time of HRM.
RESULTS: Two hundred thirty-six patients, aged 18-85 (mean 53) years, 65% female, were included. Approximately 59 (25%) patients had a major motor disorder on HRM: 19 achalasia, 24 esophagogastric junction outflow obstruction, 12 absent contractility, and 4 jackhammer. Approximately 177 (75%) patients did not have a major motor disorder: 71 ineffective esophageal motility and 106 normal motility. Having a major motor disorder was a significant predictor of dysphagia severity (Radj = 0.049, P < 0.001), but the Esophageal Hypervigilance and Anxiety Scale score carried a predictive relationship of Brief Esophageal Dysphagia Questionnaire that was 2-fold higher than having a major motor disorder: Radj = 0.118 (P < 0.001). This finding remained when evaluated by the major motor disorder group. HRM metrics were nonsignificant. DISCUSSION: In a prospective, international multicenter study, we found that esophageal hypervigilance and visceral anxiety were the strongest predictors of dysphagia severity among patients evaluated with HRM. Thus, an assessment of esophageal hypervigilance and visceral anxiety is important to incorporate when evaluating symptom severity in clinical practice and research studies.

Entities:  

Mesh:

Year:  2020        PMID: 31990697      PMCID: PMC7071929          DOI: 10.14309/ajg.0000000000000536

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   12.045


  18 in total

1.  Oesophageal pressure-flow metrics in relation to bolus volume, bolus consistency, and bolus perception.

Authors:  Taher I Omari; Lucas Wauters; Nathalie Rommel; Stamatiki Kritas; Jenifer C Myers
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

2.  Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.

Authors:  T H Taft; J R Triggs; D A Carlson; L Guadagnoli; K N Tomasino; L Keefer; J E Pandolfino
Journal:  Aliment Pharmacol Ther       Date:  2018-03-12       Impact factor: 8.171

3.  Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors.

Authors:  B T Johnston; S A Lewis; J S Collins; R J McFarland; A H Love
Journal:  Scand J Gastroenterol       Date:  1995-01       Impact factor: 2.423

4.  The Chicago Classification of esophageal motility disorders, v3.0.

Authors:  P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2014-12-03       Impact factor: 3.598

5.  Development and validation of the brief esophageal dysphagia questionnaire.

Authors:  T H Taft; M Riehl; J B Sodikoff; P J Kahrilas; L Keefer; B Doerfler; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-07-05       Impact factor: 3.598

6.  Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.

Authors:  Rena Yadlapati; Michael Tye; Laurie Keefer; Peter J Kahrilas; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2017-09-12       Impact factor: 10.864

7.  Normal Values of Esophageal Distensibility and Distension-Induced Contractility Measured by Functional Luminal Imaging Probe Panometry.

Authors:  Dustin A Carlson; Wenjun Kou; Zhiyue Lin; Monique Hinchcliff; Anjali Thakrar; Sophia Falmagne; Jacqueline Prescott; Emily Dorian; Peter J Kahrilas; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-03       Impact factor: 11.382

8.  Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study.

Authors:  C Jansson; H Nordenstedt; M-A Wallander; S Johansson; R Johnsen; K Hveem; J Lagergren
Journal:  Aliment Pharmacol Ther       Date:  2007-09-01       Impact factor: 8.171

9.  Inter- and intra-rater reproducibility of automated and integrated pressure-flow analysis of esophageal pressure-impedance recordings.

Authors:  W O Rohof; J C Myers; F A Estremera; L S Ferris; J van de Pol; G E Boeckxstaens; T I Omari
Journal:  Neurogastroenterol Motil       Date:  2013-10-25       Impact factor: 3.598

10.  High-resolution impedance manometry parameters in the evaluation of esophageal function of non-obstructive dysphagia patients.

Authors:  Maartje J Singendonk; Zhiyue Lin; Charlotte Scheerens; Jan Tack; Dustin A Carlson; Taher I Omari; John E Pandolfino; Nathalie Rommel
Journal:  Neurogastroenterol Motil       Date:  2018-11-13       Impact factor: 3.960

View more
  9 in total

Review 1.  Achalasia.

Authors:  Edoardo Savarino; Shobna Bhatia; Sabine Roman; Daniel Sifrim; Jan Tack; Sarah K Thompson; C Prakash Gyawali
Journal:  Nat Rev Dis Primers       Date:  2022-05-05       Impact factor: 52.329

2.  Distension-contraction profile of peristalsis in patients with nutcracker esophagus.

Authors:  Ali Zifan; Kazumasa Muta; Ravinder K Mittal
Journal:  Neurogastroenterol Motil       Date:  2021-04-05       Impact factor: 3.598

3.  Validation of the Short-Form Esophageal Hypervigilance and Anxiety Scale.

Authors:  Tiffany H Taft; Livia Guadagnoli; Dustin A Carlson; Walter Kou; Laurie Keefer; John Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2021-01-14       Impact factor: 11.382

4.  Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations.

Authors:  Livia Guadagnoli; Rena Yadlapati; Tiffany Taft; John E Pandolfino; Michael Tye; Laurie Keefer
Journal:  Neurogastroenterol Motil       Date:  2021-01-11       Impact factor: 3.960

Review 5.  The Lyon Consensus: Does It Differ From the Previous Ones?

Authors:  Matteo Ghisa; Brigida Barberio; Vincenzo Savarino; Elisa Marabotto; Mentore Ribolsi; Giorgia Bodini; Fabiana Zingone; Marzio Frazzoni; Edoardo Savarino
Journal:  J Neurogastroenterol Motil       Date:  2020-07-30       Impact factor: 4.924

6.  Rhythmic contraction but arrhythmic distension of esophageal peristaltic reflex in patients with dysphagia.

Authors:  Kazumasa Muta; Ravinder K Mittal; Ali Zifan
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

7.  Perception of the COVID-19 pandemic in patients with achalasia and its impact on gastrointestinal symptoms: a proof-of-concept study.

Authors:  Luigi Ruggiero; Paola Iovino; Chiara Ameno; Rossella Palma; Antonella Santonicola
Journal:  Ann Gastroenterol       Date:  2022-07-30

8.  Multiple rapid swallows and rapid drink challenge in patients with esophagogastric junction outflow obstruction on high-resolution manometry.

Authors:  Amanda J Krause; Hui Su; Joseph R Triggs; Claire Beveridge; Alexandra J Baumann; Erica Donnan; John E Pandolfino; Dustin A Carlson
Journal:  Neurogastroenterol Motil       Date:  2020-10-11       Impact factor: 3.598

9.  Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis.

Authors:  Tiffany H Taft; Dustin A Carlson; Madison Simons; Sonia Zavala; Ikuo Hirano; Nirmala Gonsalves; John E Pandolfino
Journal:  Gastroenterology       Date:  2021-06-19       Impact factor: 33.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.